Background: Chinese is the most commonly spoken world language; however, most cognitive tests were developed and validated in the West. It is essential to find out which tests are valid and practical in Chinese speaking people with suspected dementia. Objective: We therefore conducted a systematic review and meta-Analysis of brief cognitive tests adapted for Chinese-speaking populations in people presenting for assessment of suspected dementia. Methods: We searched electronic databases for studies reporting brief (≤20 minutes) cognitive test's sensitivity and specificity as part of dementia diagnosis for Chinese-speaking populations in clinical settings. We assessed quality using Centre for Evidence Based Medicine (CEBM) criteria and translation and cultural adaptation using the Manchester Translation Reporting Questionnaire (MTRQ), and Manchester Cultural Adaptation Reporting Questionnaire (MCAR). We assessed heterogeneity and combined sensitivity in meta-Analyses. Results: 38 studies met inclusion criteria and 22 were included in meta-Analyses. None met the highest CEBM criteria. Five studies met the highest criteria of MTRQ and MCAR. In meta-Analyses of studies with acceptable heterogeneity (I2 < 75%), Addenbrooke's Cognitive Examination Revised III (ACE-R ACE-III) had the best sensitivity and specificity; specifically, for dementia (93.5% 85.6%) and mild cognitive impairment (81.4% 76.7%). Conclusions: Current evidence is that the ACE-R and ACE-III are the best brief cognitive assessments for dementia and mild cognitive impairment in Chinese-speaking populations. They may improve time taken to diagnosis, allowing people to access interventions and future planning
